Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Xuyao Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1654-5550; OpenAlex author ID A5101963685. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 5

  1. Autophagy Inhibition Enhances the Antitumor Efficacy of MET Targeting in MET-High Pancreatic Cancer. Co-author DOI 10.32604/or.2026.084396↗
  2. Autophagy-targeted intervention synergized with pegaspargase: an innovative therapeutic paradigm for pancreatic cancer. Co-author DOI 10.1186/s12935-025-04074-5↗
  3. A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates alone or combined with autophagy inhibito… Co-author DOI 10.3892/ijmm.2025.5507↗
  4. Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer. Last author DOI 10.1016/j.biopha.2024.117550↗
  5. TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer. Last author DOI 10.1186/s12951-023-02183-9↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunbin Wang · 3 shared papers, 2025–2026 · strength 0.85
  2. Dandan Zhou · 2 shared papers, 2025–2026 · strength 0.60
  3. Zhe Ding · 2 shared papers, 2025 · strength 0.54
  4. Caili Xu · 2 shared papers, 2023–2024 · strength 0.37
  5. Zhiyi Min · 1 shared paper, 2026 · strength 0.32
  6. Zhe Ding · 1 shared paper, 2026 · strength 0.32
  7. Rong Fu · 1 shared paper, 2025 · strength 0.26
  8. Jing Huang · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.